BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 4766323)

  • 1. Editorial: Harnessing tumor microenvironment for gynecologic cancer therapy.
    Zhou L; Yi M
    Front Immunol; 2024; 15():1407128. PubMed ID: 38650941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ovarian neoplasms. Immunoglobulin levels in patients with primary ovarian tumors].
    Wolff JP; de Oliveira CF
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(1):75-92. PubMed ID: 1230478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T- and B-lymphocytes and the A, M and G immunoglobulins in women with malignant neoplasms of the genital organs].
    Blicharski J; Bodzoń A; Lisiewicz J; Paruch J; Piotrowski J
    Ginekol Pol; 1980 May; 51(5):389-94. PubMed ID: 6967845
    [No Abstract]   [Full Text] [Related]  

  • 4. The long-term effect of radiotherapy on the immune status of patients cured of a gynecologic malignancy.
    Halili M; Bosworth J; Romney S; Moukhtar M; Ghossein NA
    Cancer; 1976 Jun; 37(6):2875-8. PubMed ID: 949708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of immunoglobulins in blood serum in relation with prognosis of malignant ovarian diseases.
    Laurová L; Cízková J; Jandová A; Koprivová H; Zizkovský V
    Acta Univ Carol Med (Praha); 1977; 23(5-6):321-30. PubMed ID: 756682
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoglobulins of the vagina, cervical mucus and uterus].
    Koper R
    Ginekol Pol; 1981 Oct; 52(10):941-45. PubMed ID: 7037559
    [No Abstract]   [Full Text] [Related]  

  • 8. Heat shock protein expression and immunity: relevance to gynecologic oncology.
    Witkin SS
    Eur J Gynaecol Oncol; 2001; 22(4):249-56. PubMed ID: 11695802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor antigenicity and the immune system in gynecological cancer: a review.
    Freedman RS; Bowen J; Herson J; Wharton JT; Rutledge FN
    Gynecol Oncol; 1980 Feb; 9(1):43-62. PubMed ID: 6243598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical indicators of neoplasms of the female genital organs].
    Kamiński K
    Ginekol Pol; 1988 Jun; 59(6):376-80. PubMed ID: 3069618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunoglobulin level in malignant gynecologic diseases and tumor patients].
    Pulay T; Keller G; Krommer K; Kovács C
    Orv Hetil; 1973 Dec; 114(52):3146-8. PubMed ID: 4766323
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.